Patients’ Experiences of Cancer-Related Cognitive Impairment Across Breast and Gynecologic Cancers: A Qualitative Meta-Synthesis

Cancer-related cognitive impairment (CRCI), often described as difficulties with memory, attention, processing speed, and executive functioning, is frequently reported by people receiving or having completed treatment for breast and gynecologic cancers. Although quantitative studies have characterized prevalence and correlates, qualitative evidence is essential for understanding how CRCI is experienced, interpreted, and managed in daily life, and how it intersects with identity, roles, relationships, and survivorship trajectories.